Oversubscribed Capital Raising to Fast Track New Strategy
Filed with ASX · · 4 pages · English
Earlier from Conneqt Health
- AtCor Announces First Steps in Major Strategic Repositioning
- AtCors XCEL device clinically validated in 3rd party study
- AtCor and PhysioAge Systems announce supply agreement
- AtCor secures $1.0 million new pharmaceutical trial contract
- AtCor appoints Craig Cooper as CEO
Later from Conneqt Health
- Underwritten Rights Issue Prospectus Lodged with ASIC
- Blumio Wearable Cardio Trial with Macquarie University
- AtCor Announces Wearable Trial with Macquarie University
- CardieX (AtCor) Entitlements Issue Heavily Over Subscribed
- CardieX Makes First Investment in Wearable Tech Partnership
Follow Conneqt Health into a list and get an email when it puts out news.
Follow Conneqt Health